Iron Deficiency Anemia Therapy Market

Oral iron therapy is estimated to account for 46.0% of treatment revenue in 2026 while oral administration represents 59.0% across delivery routes. Hospital pharmacies are projected to capture 44.0% of distribution revenue because treatment completion requires confirmed deficiency and suitable dosing. Poor oral tolerance or limited infusion capacity can still interrupt care.